| 000 | 01419 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513033026.0 | ||
| 264 | 0 | _c19951208 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0918-6158 | ||
| 024 | 7 |
_a10.1248/bpb.18.996 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInouye, Y | |
| 245 | 0 | 0 |
_aStructure-activity correlationship and strain specificity of polyoxometalates in anti-human immunodeficiency virus activity. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _cJul 1995 |
||
| 300 |
_a996-1000 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytopathogenic Effect, Viral _xdrug effects |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Direct |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMolybdenum _xpharmacology |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTungsten Compounds _xpharmacology |
| 650 | 0 | 4 |
_aVanadium Compounds _xpharmacology |
| 650 | 0 | 4 |
_aViral Proteins _xbiosynthesis |
| 700 | 1 | _aFujimoto, Y | |
| 700 | 1 | _aSugiyama, M | |
| 700 | 1 | _aYoshida, T | |
| 700 | 1 | _aYamase, T | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 18 _gno. 7 _gp. 996-1000 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.18.996 _zAvailable from publisher's website |
| 999 |
_c7580698 _d7580698 |
||